Research
Online Inquiry

D-Luciferin, Potassium Salt

Cat.No: RESK-0258 Datasheet

Quantities:
- +
Product Details Related Products
Product Name D-Luciferin, Potassium Salt
Catalog No. RESK-0258
Description D-Luciferin potassium salt is a widely used substrate of firefly luciferase, applied throughout biotechnology and especially in in vivo bioluminescence imaging (BLI). In the presence of ATP and luciferase, the substrate is oxidized and emits light; when luciferin is in excess, the number of emitted photons is positively correlated with the luciferase concentration. Cells transfected with a plasmid carrying the luciferase gene (Luc) can be introduced into research animals such as mice and rats; after substrate injection, changes in light intensity are detected by BLI, enabling real-time monitoring of disease progression or the therapeutic efficacy of drugs. The reaction can also be used to indicate energy status or vital signs through the influence of ATP on the reaction system. It has been used, for example, for in vivo pharmacodynamic evaluation of anti-tumor drugs, with bioluminescent signals of lung tumor formation and distant metastasis quantified by BLI.
Intended Use In vivo bioluminescence imaging (BLI) in small animals
In vitro luciferase reporter gene assays
Microbial and viral monitoring
Pyrosequencing
ATP-based indication of energy status or vital signs
Principle / Technology In the presence of ATP and firefly luciferase, D-luciferin (substrate) is oxidized and emits light. When the substrate is in excess, the emitted photon output is directly proportional to the luciferase concentration. The reaction is chemiluminescent and requires no excitation light; the detection wavelength of firefly luciferin is 560 nm.
Detection Method Bioluminescence detection (no excitation light required; detection wavelength 560 nm for firefly luciferin). The signal can be measured with a luminometer, scintillation counter, or an in vivo small-animal imaging system equipped with a bioluminescence module. A multifunctional microplate reader can be used only after confirming with the manufacturer that a luminescence detection module is installed (fluorescence microscopes cannot be used).
Sample Type Luciferase-expressing cells (e.g., Luc-transduced tumor cells); research animals such as mice and rats carrying luciferase-expressing cells for in vivo imaging.
Performance Range / Specifications Appearance: pale yellow powder
Solubility: readily soluble in water (60 mg/mL)
Purity (HPLC): >99%
CAS No.: 115144-35-9
Molecular formula: C11H7N2O3S2 K
Molecular weight: 318.42 g/mol
Specificity Substrate of firefly luciferase. The compound is identical to products named firefly luciferin or beetle luciferin: (S)-2-(6-hydroxy-2-benzothiazolyl)-2-thiazoline-4-carboxylic acid.
Reaction Conditions / Protocol Route of administration: intraperitoneal (i.p.) or tail-vein injection; i.p. injection diffuses more slowly and gives longer-lasting luminescence, while intravenous injection diffuses quickly but with a short luminescence duration
Suggested initial dose (from literature): 150 mg substrate per kg mouse body weight; e.g., 3 mg per 20 g C57 mouse per imaging session, so 100 mg is sufficient for about 33 mice (excluding loss)
Kinetics after i.p. injection in mice: luciferase-expressing cells begin to emit light about 3 min post-injection; signal reaches a stable maximum at about 10 min, remains at the peak plateau for 10-15 min, then decays; detection is recommended within 10-15 min post-injection
A pilot experiment to establish the luciferase kinetic curve is recommended to determine the optimal signal detection time and plateau
Components / Formulation D-Luciferin potassium salt, supplied as a powder.
Storage Conditions Store at -25 to -15 °C in a dry place, protected from light.
Shelf Life 1 year when stored at -25 to -15 °C, dry and protected from light.
Package Specifications 100 mg
500 mg
1 g
5× 1 g
5 g
Product Form Pale yellow powder
Quality Control Purity verified by HPLC (>99%).
Purity >99% (HPLC)
Concentration Readily soluble in water at 60 mg/mL; distilled water is recommended for in vitro use. The working dose in mice is typically 150 mg/kg body weight.
Molecular Weight 318.42 g/mol
Source / Origin CAS No. 115144-35-9. Synonyms: (S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic acid potassium salt; D-Luciferin firefly, potassium salt.
Expiration Date / Stability Powder stored protected from light at -20 °C or -70 °C is stable for at least 1 year; the labeled shelf life is 1 year at -25 to -15 °C (dry, protected from light).
Compatibility The substrate readily crosses the blood-brain barrier, the placental barrier and the blood-testis barrier, and can enter living cells. The potassium salt dissolves in water at 60 mg/mL (the sodium salt up to 100 mg/mL; the free acid is poorly soluble in water). The potassium salt is the most frequently used form in in vivo studies and generally causes no toxic side effects in animals.
Recommended Buffer System Dissolve in distilled water or a physiologically compatible buffer. For in vitro imaging, the required ATP and Mg2+ should be supplied by the cell culture medium; intracellular ATP and Mg2+ are usually sufficient to drive the reaction in most cell types.
Application Notes / Precautions Protect from light during storage and handling.
Establish a luciferase kinetic curve in a pilot experiment to define the peak signal time and plateau.
Successful in vivo imaging requires expression of the luciferase gene in the target tissue or cells, successful substrate injection, and consideration of tissue thickness at the luminescent site; if no signal is observed, check these factors.
Higher substrate purity (>=99%) is recommended, since impurities may inhibit intracellular enzymes and could reduce experimental performance or harm animals.

For research use only, not for clinical use.

0
0

There is no product in your cart.